Planet Briefing

First published · Last updated

Post‑Marketing Surveillance of the Safety and Effectiveness of Emicizumab in Japanese Patients With Congenital Haemophilia A With Inhibitors

Journal article reporting post-marketing surveillance of the safety and effectiveness of emicizumab in Japanese patients with congenital haemophilia A with inhibitors. The supplied source data included only the publisher and content type and did not include study details or results.

Categories: public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
3/10
Geographic reach
4/10
Global importance
3/10
Impact magnitude
3/10
Positivity
5/10
Urgency
1/10

Why it matters

This surveillance evaluates a treatment's safety and effectiveness for a defined patient population in Japan.

Location

Sources

Report an issue